BCSFVSDNA• 28 Days (Normalized)
BCSF vs DNA (Bain Capital Specialty Finance Inc. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BCSF Performance $10.82
-6.96%
Bain Capital Specialty Finance Inc.
Normalized Baseline0.00%
DNA Performance $12.41
+78.82%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-85.78 pts
DNA outperforming by 85.78 percentage points
BCSFDNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BCSF DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | BCSF Price | BCSF Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $10.82 | -6.96% | $12.41 | +78.82% | -85.78% |
| Oct 05, 2026 | $10.90 | -6.28% | $14.98 | +115.85% | -122.13% |
| Oct 02, 2026 | $11.05 | -4.99% | $12.35 | +77.95% | -82.94% |
| Oct 01, 2026 | $- | $12.50 | +80.12% | - | |
| Sep 30, 2026 | $- | $12.83 | +84.87% | - | |
| Sep 29, 2026 | $- | $11.96 | +72.33% | - | |
| Sep 28, 2026 | $- | $10.46 | +50.72% | - | |
| Sep 25, 2026 | $11.08 | -4.73% | $10.66 | +53.60% | -58.33% |
| Sep 24, 2026 | $11.12 | -4.39% | $10.25 | +47.69% | -52.08% |
| Sep 23, 2026 | $11.07 | -4.82% | $8.58 | +23.63% | -28.45% |
| Sep 22, 2026 | $11.22 | -3.53% | $9.37 | +35.01% | -38.54% |
| Sep 21, 2026 | $11.21 | -3.61% | $7.98 | +14.99% | -18.60% |
| Sep 18, 2026 | $11.09 | -4.64% | $7.88 | +13.54% | -18.18% |
| Sep 17, 2026 | $11.30 | -2.84% | $7.84 | +12.97% | -15.81% |
| Sep 16, 2026 | $11.08 | -4.73% | $7.06 | +1.73% | -6.46% |
Page 1 of 2